Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Leslie Ballas, MD

    TitleAssistant Professor of Clinical Radiation Oncology
    SchoolKeck School of Medicine of USC
    DepartmentRadiation Oncology
    AddressNOR G350 1441 EASTLAKE AVE
    Health Sciences Campus
    Los Angeles California 90033
    Phone+1 323 865 3050
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      After residency, I spent time on the faculty at MD Anderson Cancer Center treating hematologic malignancies (leukemia, lymphoma and multiple myeloma). I have considerable experience treating this patient population. Because many lymphomas are highly curable, management of long term side effects from treatment is essential. I have used many different treatment techniques and modalities to minimize radiation dose to normal structures, thereby minimizing late effects from treatment. I also have a great deal of experience working with cutaneous lymphomas and the management of this category of lymphomas.

      Dr. Leslie Ballas also specializes in cancers of the genitourinary tract, including malignancies of the prostate, urinary bladder, testicle, and kidney. Her research has focused on improving quality of life for men with prostate cancer. She is involved in the development of cancer treatment clinical trials for patients with genitourinary cancers. And has brought multiple genitourinary cooperative group studies to USC. Dr. Ballas’ interests include advanced technology integration into cancer therapeutics, including image-guide radiation therapy (IGRT), stereotactic body radiotherapy (SBRT), and intensity modulated radiotherapy (IMRT).


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Dorff TB, Ballas L, Schuckman AK. Current Management Strategy for Penile Cancer and Future Directions. Curr Oncol Rep. 2017 Aug; 19(8):54. PMID: 28664471.
        View in: PubMed
      2. Yoon J, Ballas L, Desai B, Jadvar H. Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting 18F-Sodium Fluoride Positron Emission Tomography-Computed Tomography Positivity for First Bone Metastases in Patients with Biochemical Recurrence after Radical Prostatectomy. World J Nucl Med. 2017 Jul-Sep; 16(3):229-236. PMID: 28670183.
        View in: PubMed
      3. Yu SS, Ballas L, Skinner EC, Dorff TB, Sadeghi S, Quinn DI. Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment. Clin Adv Hematol Oncol. 2017 Jul; 15(7):543-551. PMID: 28749918.
        View in: PubMed
      4. Yu SS, Dorff TB, Ballas L, Sadeghi S, Skinner EC, Quinn DI. Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease. Clin Adv Hematol Oncol. 2017 Jun; 15(6):466-477. PMID: 28749907.
        View in: PubMed
      5. Ballas L, Sargos P, Orré M, Bian SX, Daneshmand S, Eapen LJ. Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study. Clin Genitourin Cancer. 2017 May 10. PMID: 28558986.
        View in: PubMed
      6. Baumann BC, Sargos P, Eapen LJ, Efstathiou JA, Choudhury A, Bahl A, Murthy V, Ballas L, Fonteyne V, Richaud PM, Zaghloul MS, Christodouleas JP. The Rationale for Post-Operative Radiation in Localized Bladder Cancer. Bladder Cancer. 2017 Jan 27; 3(1):19-30. PMID: 28149931.
        View in: PubMed
      7. Winkfield KM, Advani RH, Ballas L, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS. ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology (Williston Park). 2016 12 15; 30(12):1099-103, 1106-8. PMID: 27987203.
        View in: PubMed
      8. Dhakal S, Advani R, Ballas L, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol. 2016 Dec; 39(6):535-544. PMID: 27643717.
        View in: PubMed
      9. Ballas L, de Castro Abreu AL, Quinn DI. What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer. J Nucl Med. 2016 Oct; 57(Suppl 3):6S-12S. PMID: 27694176.
        View in: PubMed
      10. Pinnix CC, Osborne EM, Chihara D, Lai P, Zhou S, Ramirez MM, Oki Y, Hagemeister FB, Rodriguez AM, Samaniego F, Fowler N, Romaguera JE, Turturro F, Fayad L, Westin JR, Nastoupil L, Neelapu SS, Cheah CY, Dabaja BS, Milgrom SA, Smith GL, Horace P, Milbourne A, Wogan CF, Ballas L, Fanale MA. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. JAMA Oncol. 2016 Aug 01; 2(8):1065-9. PMID: 27227654.
        View in: PubMed
      11. Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. J Urol. 2015 Aug; 194(2):378-85. PMID: 25711194; PMCID: PMC4834920.
      12. Ballas L. Modern radiotherapeutic strategies in the management of lymphoma. Future Oncol. 2015; 11(6):1011-20. PMID: 25760980.
        View in: PubMed
      13. Ballas L, Hu BR, Quinn DI. Chromoplexy and hypoxic microenvironment drives prostate cancer. Lancet Oncol. 2014 Dec; 15(13):1419-21. PMID: 25456359.
        View in: PubMed
      14. Jhaveri PM, Sun Z, Ballas L, Followill DS, Hoffman KE, Jiang J, Smith BD. Emergence of integrated urology-radiation oncology practices in the State of Texas. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):15-9. PMID: 22789491; PMCID: PMC3837447.
      15. Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Med Dosim. 2012; 37(4):374-82. PMID: 22513213.
        View in: PubMed
      16. Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer. 2012 Jan 01; 118(1):112-7. PMID: 21692072.
        View in: PubMed
      17. Hei TK, Ballas L, Brenner DJ, Geard CR. Advances in radiobiological studies using a microbeam. J Radiat Res. 2009 Mar; 50 Suppl A:A7-A12. PMID: 19346688; PMCID: PMC3889709.
      18. Ballas L, Elkin EB, Schrag D, Minsky BD, Bach PB. Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1204-11. PMID: 17145535.
        View in: PubMed
      19. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas L, Heath WF, Stramm LE, Feener EP, King GL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996 May 03; 272(5262):728-31. PMID: 8614835.
        View in: PubMed